These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29728051)

  • 21. Long noncoding RNAs (lncRNAs) in triple negative breast cancer.
    Wang Q; Gao S; Li H; Lv M; Lu C
    J Cell Physiol; 2017 Dec; 232(12):3226-3233. PubMed ID: 28138992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast Cancer.
    Karn T; Jiang T; Hatzis C; Sänger N; El-Balat A; Rody A; Holtrich U; Becker S; Bianchini G; Pusztai L
    JAMA Oncol; 2017 Dec; 3(12):1707-1711. PubMed ID: 28750120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer.
    Liu YR; Jiang YZ; Xu XE; Yu KD; Jin X; Hu X; Zuo WJ; Hao S; Wu J; Liu GY; Di GH; Li DQ; He XH; Hu WG; Shao ZM
    Breast Cancer Res; 2016 Mar; 18(1):33. PubMed ID: 26975198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A.
    Szarc Vel Szic K; Declerck K; Crans RAJ; Diddens J; Scherf DB; Gerhäuser C; Vanden Berghe W
    Oncotarget; 2017 Jun; 8(25):40434-40453. PubMed ID: 28467815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
    Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
    Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of sample-specific regulations using integrative network level analysis.
    Liu C; Louhimo R; Laakso M; Lehtonen R; Hautaniemi S
    BMC Cancer; 2015 Apr; 15():319. PubMed ID: 25928379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers.
    Yue Y; Astvatsaturyan K; Cui X; Zhang X; Fraass B; Bose S
    PLoS One; 2016; 11(3):e0149661. PubMed ID: 26930401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deviance residuals-based sparse PLS and sparse kernel PLS regression for censored data.
    Bastien P; Bertrand F; Meyer N; Maumy-Bertrand M
    Bioinformatics; 2015 Feb; 31(3):397-404. PubMed ID: 25286920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive Biomarker Profiling of > 6000 Breast Cancer Patients Shows Heterogeneity in TNBC, With Treatment Implications.
    Millis SZ; Gatalica Z; Winkler J; Vranic S; Kimbrough J; Reddy S; O'Shaughnessy JA
    Clin Breast Cancer; 2015 Dec; 15(6):473-481.e3. PubMed ID: 26051240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Machine Learning-Based Ensemble Recursive Feature Selection of Circulating miRNAs for Cancer Tumor Classification.
    Lopez-Rincon A; Mendoza-Maldonado L; Martinez-Archundia M; Schönhuth A; Kraneveld AD; Garssen J; Tonda A
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32635415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNAs-mediated cell fate in triple negative breast cancers.
    Sui X; Wang X; Han W; Li D; Xu Y; Lou F; Zhou J; Gu X; Zhu J; Zhang C; Pan H
    Cancer Lett; 2015 May; 361(1):8-12. PubMed ID: 25748387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integration of RNA-Seq data with heterogeneous microarray data for breast cancer profiling.
    Castillo D; Gálvez JM; Herrera LJ; Román BS; Rojas F; Rojas I
    BMC Bioinformatics; 2017 Nov; 18(1):506. PubMed ID: 29157215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-throughput «Omics» technologies: New tools for the study of triple-negative breast cancer.
    Judes G; Rifaï K; Daures M; Dubois L; Bignon YJ; Penault-Llorca F; Bernard-Gallon D
    Cancer Lett; 2016 Nov; 382(1):77-85. PubMed ID: 26965997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triple negative breast cancer: a multi-omics network discovery strategy for candidate targets and driving pathways.
    Karagoz K; Sinha R; Arga KY
    OMICS; 2015 Feb; 19(2):115-30. PubMed ID: 25611337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics of triple-negative breast cancer: Implications for patient care.
    Afghahi A; Telli ML; Kurian AW
    Curr Probl Cancer; 2016; 40(2-4):130-140. PubMed ID: 28340968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy.
    Darb-Esfahani S; Denkert C; Stenzinger A; Salat C; Sinn B; Schem C; Endris V; Klare P; Schmitt W; Blohmer JU; Weichert W; Möbs M; Tesch H; Kümmel S; Sinn P; Jackisch C; Dietel M; Reimer T; Loi S; Untch M; von Minckwitz G; Nekljudova V; Loibl S
    Oncotarget; 2016 Oct; 7(42):67686-67698. PubMed ID: 27611952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy.
    Honma N; Horii R; Ito Y; Saji S; Younes M; Iwase T; Akiyama F
    BMC Cancer; 2015 Oct; 15():698. PubMed ID: 26472348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase.
    Bayraktar R; Pichler M; Kanlikilicer P; Ivan C; Bayraktar E; Kahraman N; Aslan B; Oguztuzun S; Ulasli M; Arslan A; Calin G; Lopez-Berestein G; Ozpolat B
    Oncotarget; 2017 Feb; 8(7):11641-11658. PubMed ID: 28036267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the molecular subtypes of triple-negative breast cancer among non-Asian and Taiwanese women.
    Tseng LM; Chiu JH; Liu CY; Tsai YF; Wang YL; Yang CW; Shyr YM
    Breast Cancer Res Treat; 2017 Jun; 163(2):241-254. PubMed ID: 28299476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triple negative breast cancer in people of North East India: critical insights gained at a regional cancer centre.
    Sharma M; Sharma JD; Sarma A; Ahmed S; Kataki AC; Saxena R; Sharma D
    Asian Pac J Cancer Prev; 2014; 15(11):4507-11. PubMed ID: 24969877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.